Partnership Forum: In June 2013, AMCP convened a group of experts to explore how managed care pharmacy departments can work with their medication therapy management (MTM) and other pharmacists to collaborate in redesigning the Medication Reconciliation (MedRec) process for transitions of care.
On May 23, 2013, CMS finalized a rule that will allow for certain MTM activities and fraud reduction activities to count toward Medicare Part D and Medicare Advantage medical loss ratio (MLR).
The Centers for Medicare and Medicaid Services (CMS), will allow for certain MTM activities and fraud reduction activities to count toward Medicare Part D and Medicare Advantage medical loss ratio (MLR)
This final rule implements new medical loss ratio (MLR) requirements for the Medicare Advantage Program and the Medicare Prescription Drug Benefit Program established under the Patient Protection and Affordable Care Act
This document has been developed by AMCP and ASHP to assist residency program directors, and their organizations, who are considering developing a PGY1 Managed Care Pharmacy Residency Program to undertake a self-assessment to help identify whether or not the operational functions and pharmacist practice environment in the organization is aligned with the unique settings, functions, and practice environment for which the PGY1 Managed Care Pharmacy Accreditation Standard and the associated Outcomes, Goals and Objectives were developed and intended.